New chairman for Pharmaniaga


In a filing with Bursa Malaysia yesterday, the integrated pharmaceutical group said Zainal Abidin will replace Datuk Seri Mohamed Shazalli Ramly, who will be redesignated as a non-independent director of the company.

KUALA LUMPUR: Pharmaniaga Bhd has announced the appointment of Datuk Seri Zainal Abidin Mohd Rafique as its non- independent and non-executive chairman effective Feb 1, 2022, Bernama reported.

In a filing with Bursa Malaysia yesterday, the integrated pharmaceutical group said Zainal Abidin will replace Datuk Seri Mohamed Shazalli Ramly, who will be redesignated as a non-independent director of the company.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Oil falls on prospect of higher-for-longer US rates
Chin Hin taps Ajiya for two-year RM250mil loan
MI Technovation posts three-fold surge in net profit
Wellness a top priority
InNature diversifies into the F&B industry
Tolerance for a cheaper yuan may be temporary
Yinson’s RM16bil debt too big to ignore
Leap in operating income for UOB’s retail banking
Paramount emerges as major shareholder in EWI
China’s push for greener aluminium hit by erratic rains, power cuts

Others Also Read